WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for KNSA

Based on 1 analyst offering 12 month price targets for Kiniksa Pharmaceuticals Ltd.
Min Forecast
$32.00+85.29%
Avg Forecast
$32.00+85.29%
Max Forecast
$32.00+85.29%

Should I buy or sell KNSA stock?

Based on 1 analyst offering ratings for Kiniksa Pharmaceuticals Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KNSA stock forecasts and price targets.

KNSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-07-26

1 of 1

Forecast return on equity

Is KNSA forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is KNSA forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

KNSA revenue forecast

What is KNSA's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$255.7M+2.79%
Avg 2 year Forecast
$325.6M+30.9%
Avg 3 year Forecast
$426.2M+71.32%
KNSA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KNSA revenue growth forecast

How is KNSA forecast to perform vs Biotechnology companies and vs the US market?
Company
19.18%
Industry
34.65%
Market
7.68%
KNSA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KNSA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KNSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KNSA$17.27$32.00+85.29%Strong Buy
ARDX$5.23$9.63+84.03%Strong Buy
CVAC$5.48$8.00+45.99%Sell
SAGE$20.01$28.64+43.14%Hold
AGIO$22.05$34.00+54.20%Hold
View Top Biotech Stocks

Kiniksa Pharmaceuticals Stock Forecast FAQ

Is Kiniksa Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KNSA) stock is to Strong Buy KNSA stock.

Out of 1 analyst, 1 (100%) are recommending KNSA as a Strong Buy, 0 (0%) are recommending KNSA as a Buy, 0 (0%) are recommending KNSA as a Hold, 0 (0%) are recommending KNSA as a Sell, and 0 (0%) are recommending KNSA as a Strong Sell.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals stock.

What is KNSA's revenue growth forecast for 2023-2025?

(NASDAQ: KNSA) Kiniksa Pharmaceuticals's forecast annual revenue growth rate of 19.18% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Kiniksa Pharmaceuticals's revenue in 2023 is $248,748,000.On average, 2 Wall Street analysts forecast KNSA's revenue for 2023 to be $17,984,462,042, with the lowest KNSA revenue forecast at $17,917,288,914, and the highest KNSA revenue forecast at $18,051,635,171. On average, 2 Wall Street analysts forecast KNSA's revenue for 2024 to be $22,902,168,062, with the lowest KNSA revenue forecast at $22,437,231,542, and the highest KNSA revenue forecast at $23,367,104,582.

In 2025, KNSA is forecast to generate $29,975,041,249 in revenue, with the lowest revenue forecast at $29,546,328,981 and the highest revenue forecast at $30,403,753,517.

What is KNSA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: KNSA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is KNSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KNSA price target, the average KNSA price target is $32.00, with the highest KNSA stock price forecast at $32.00 and the lowest KNSA stock price forecast at $32.00.

The Wall Street analyst predicted that Kiniksa Pharmaceuticals's share price could reach $32.00 by Jul 26, 2024. The average Kiniksa Pharmaceuticals stock price prediction forecasts a potential upside of 85.29% from the current KNSA share price of $17.27.

What is KNSA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: KNSA) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.